Hypertension in women: the role of progesterone and aldosterone

References

• Wolf-Maier K, Cooper RS, Banegas JR, et al Hypertension prevalence and blood pressure levels in 6 European Countries, Canada, and the United States. JAMA 2003;289:2363–2369
   PubMed Web of Science ®Google Scholar
• Dasgupta K, O'Loughlin J, Chen S, et al Emergence of sex difference in prevalence of high systolic blood pressure: analysis of a longitudinal adolescent cohort. Circulation 2006;114:2663–2670
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Facchetti R, Cesana GC, Modena MG, Pirelli A, Sega R, on behalf of the SIMONA participants. Menopause-related blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens 2005;23:2269–2276
   PubMed Web of Science ®Google Scholar
• Reckelhoff JF, Zhang H, Srivastava K. Gender differences in development of hypertension in spontaneously hypertensive rats. Role of the renin-angiotensin system. Hypertension 2000;35:480–483
   PubMed Web of Science ®Google Scholar
• Harrison-Bernhard LM, Schulman IH, Raij L. Postovariectomy hypertension is linked to increased renal AT1 receptor and salt sensitivity. Hypertension 2003;42:1157–1163
   PubMed Web of Science ®Google Scholar
• Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903–1913
   PubMed Web of Science ®Google Scholar
• Vasan RS, Larson MG, Leip EP, et al Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345:1291–1297
   PubMed Web of Science ®Google Scholar
• Guidelines Committee. 2007 Guidelines for the Management of Arterial Hypertension. J Hypertens 2007;25:1105–1187
   PubMed Web of Science ®Google Scholar
• Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension, an age-old debate. Hypertension 2008;51:952–959
   PubMed Web of Science ®Google Scholar
• Landau RL, Bergenstal DM, Lugibihl K, Kascht ME. The metabolic effects of progesterone in man. J Clin Endocrinol Metab 1955;15:1194–1215
   PubMed Web of Science ®Google Scholar
• Derkx FH, Steunkel C, Schalekamp MP, Visser W, Huisveld IH, Schalekamp MA. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. J Clin Endocrinol Metab 1986;63:1008–1015
   PubMed Web of Science ®Google Scholar
• Oelkers W. Effects of estrogens and progestogens on the renin–aldosterone system and blood pressure. Steroids 1996;61:166–171
   PubMed Web of Science ®Google Scholar
• Crane MG, Harris JJ. Effects of estrogens and gestagens on the renin–aldosterone system. In Fregly MJ, Fregly MS, eds. Oral Contraceptives and High Blood Pressure. Gainesville, Florida: Dolphin Press, 1974.
   Google Scholar
• Oelkers W, Schöneshöfer M, Blümel A. Effects of progesterone and four synthetic progestagens on sodium balance and the renin–aldosterone system in man. J Clin Endocrinol Metab 1974;39:882–890
   PubMed Web of Science ®Google Scholar
• Calhoun DA, Oparil S. High blood pressure in women. Int J Fertil 1997;42:198–205
   Google Scholar
• Cifkova R, Pitha J, Lejskova M, Lanska V, Zecova S. Blood pressure around the menopause: a population study. J Hypertension 2008;26:1976–1982
   PubMed Web of Science ®Google Scholar
• Adams MR, Kaplan JR, Manuck SB, et al Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 1990;10:1051–1057
   PubMedGoogle Scholar
• Adams MR, Register TC, Golden DL, Wagner JD, Williams JK. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol 1997;17:217–221
   PubMed Web of Science ®Google Scholar
• Rosano GM, Fini M. Comparative cardiovascular effects of different progestins in menopause. Int J Fertil Womens Med 2001;46:248–256
   PubMed Web of Science ®Google Scholar
• Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004;291:1701–1712
   PubMed Web of Science ®Google Scholar
• Manson JE, Hsia J, Johnson KC, et al Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003;349:523–534
   PubMed Web of Science ®Google Scholar
• Weinberger MH. Pathogenesis of salt sensitivity of blood pressure. Curr Hypertens Rep 2006;8:166–170
   PubMed Web of Science ®Google Scholar
• Pechère-Bertschi A, Burnier M. Female sex hormones, salt, and blood pressure regulation. Am J Hypertens 2004;17:994–1001
   PubMed Web of Science ®Google Scholar
• Pechère-Bertschi A, Maillard M, Stadler H, Brunner HR, Burnier M. Renal segmental tubular response during the normal menstrual cycle. Kidney Int 2002; 61:425–431
   PubMed Web of Science ®Google Scholar
• Schulman IH, Aranda P, Raij L, Veronesi M, Aranda FJ, Martin R. Surgical menopause increases salt sensitivity of blood pressure. Hypertension 2006;47:1168–1174
   PubMed Web of Science ®Google Scholar
• Morimoto A, Uzu T, Fujii T, et al Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 1997;350:1734–1737
   PubMed Web of Science ®Google Scholar
• Cubeddu LX, Hoffmann IS, Aponte LM, et al Role of salt sensitivity, blood pressure, and hyperinsulinemia in determining high upper normal levels of urinary albumin excretion in a healthy adult population. Am J Hypertens 2003;16:343–349
   PubMed Web of Science ®Google Scholar
• Schulman IH, Raij L. Salt sensitivity and hypertension after menopause: role of nitric oxide and angiotensin II. Am J Nephrol 2006;26:170–180
   PubMed Web of Science ®Google Scholar
• Szmuilowicz ED, Adler GK, Williams JS, et al Relationship between aldosterone and progesterone in the human menstrual cycle. J Clin Endocrin Metab 2006;91:3981–3987
   PubMed Web of Science ®Google Scholar
• Pechère-Bertschi A, Burnier M. Gonadal steroids, salt-sensitivity and renal function. Curr Opin Nephrol Hypertens 2007;16:16–21
   PubMed Web of Science ®Google Scholar
• Connell JM, Davis E. The new biology of aldosterone. J Endocrinol 2005;186:1–20
   PubMed Web of Science ®Google Scholar
• Krozowski ZS, Funder JW. Renal mineralocorticoid receptors and hippocampal corticosterone-binding species have identical intrinsic steroid specificity. Proc Natl Acad Sci USA 1983;80:6056–6060
   PubMed Web of Science ®Google Scholar
• Pearce P, Funder JW. High affinity aldosterone binding sites (type I receptors) in rat heart. Clin Exp Pharmacol Physiol 1987;14:859–866
   PubMed Web of Science ®Google Scholar
• Fujisawa G, Dilley R, Fullerton MJ, Funder JW. Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration. Endocrinology 2001;142:3625–3631
   PubMed Web of Science ®Google Scholar
• Oberleithner H, Riethmüller C, Ludwig T, Hausberg M, Schillers H. Aldosterone remodels human endothelium. Acta Physiol 2006;187:305–312
   PubMed Web of Science ®Google Scholar
• Schlaich MP, Schobel HP Hilgers K, Schmieder RE. Impact of aldosterone on left ventricular structure and function in young normotensive and mildly hypertensive subjects. Am J Cardiol 2000;85:1199–1206
   PubMed Web of Science ®Google Scholar
• Rocha R, Stier CT, Kifor I, et al Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000;141:3871–3878
   PubMed Web of Science ®Google Scholar
• Rocha R, Stier CT. Pathophysiological effects of aldosterone in cardiovascular tissues. Trends Endocrinol Metab 2001;12:308–314
   PubMed Web of Science ®Google Scholar
• Funder JW. New biology of aldosterone, and experimental studies on the selective aldosterone blocker eplerenone. Am Heart J 2002;144:S8–11
   PubMed Web of Science ®Google Scholar
• Freel EM, Connell JM. Mechanisms of hypertension: the expanding role of aldosterone. J Am Soc Nephrol 2004;15:1993–2001
   PubMed Web of Science ®Google Scholar
• Rahmouni K, Correia MLG, Haynes WG, Mark AL. Obesity-associated hypertension. New insights into mechanisms. Hypertension 2005;45:9–14
   PubMed Web of Science ®Google Scholar
• El-Atat FA, Stas SN, McFarlane SI, Sowers JR. The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 2004;15:2816–2827
   PubMed Web of Science ®Google Scholar
• Catena C, Lapenna R, Baroselli S, et al Insulin sensitivity in patients with primary aldosteronism: a follow up study. J Clin Endocrinol Metab 2006;91:3457–3463
   PubMed Web of Science ®Google Scholar
• Caprio M, Zennaro MC, Feve B, Mammi C, Fabbri A, Rosano G. Potential role of progestogens in the control of adipose tissue and salt sensitivity via interaction with the mineralocorticoid receptor. Climacteric 2008;11:258–264
   PubMed Web of Science ®Google Scholar
• Kagawa CM, Cella JA, Van Arman CG. Action of new steroids in blocking effects of aldosterone and desoxycorticosterone on salt. Science 1957;126:1015–1016
   PubMed Web of Science ®Google Scholar
• Pollow K, Juchem M, Elger W, Jacobi N, Hoffmann G, Möbus V. Dihydrospirorenone (ZK30595): a novel synthetic progestagen – characterization of binding to different receptor proteins. Contraception 1992;46:561–574
   PubMed Web of Science ®Google Scholar
• De Gasparo M, Joss U, Ramjoué HP, et al Three new epoxy-spirolactone derivatives: characterisation in vivo and in vitro. J Pharmacol Exp Ther 1987;240:650–656
   PubMed Web of Science ®Google Scholar
• Elger W, Beier S, Pollow K, Garfield R, Qing Shi S, Hillisch A. Conception and pharmacodynamic profile of drospirenone. Steroids 2003;68:891–905
   PubMed Web of Science ®Google Scholar
• Muhn P, Krattenmacher R, Beier S, Elger W, Schillinger E. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Contraception 1995;51:99–110
   PubMed Web of Science ®Google Scholar
• Sitruk-Ware R. New progestogens. A review of their effects in perimenopausal and postmenopausal women. Drugs Aging 2004;21:865–883
   PubMed Web of Science ®Google Scholar
• Preston RA, Alonso A, Panzitta D, Zhang P, Karara AH. Additive effect of drospirenone/17β-estradiol in hypertensive postmenopausal women receiving enalapril. Am J Hypertens 2002;15:816–822
   PubMed Web of Science ®Google Scholar
• White WB, Pitt B, Preston RA, Hanes V. Antihypertensive effects of drospirenone with 17β-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension. Circulation 2005;112:1979–1984
   PubMed Web of Science ®Google Scholar
• White WB, Hanes V, Chauhan V, Pitt B. Effects of a new hormone therapy, drospirenone and 17β-estradiol, in postmenopausal women with hypertension. Hypertension 2006;48:246–253
   PubMed Web of Science ®Google Scholar
• Preston RA, White WB, Pitt B, Bakris G, Norris PM, Hanes V. Effects of drospirenone/17β-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women. Am J Hypertens 2005;18:797–804
   PubMed Web of Science ®Google Scholar
• Preston RA, Norris PM, Alonso AB, Ni P, Hanes V, Karara AH. Randomized, placebo-controlled trial of drospirenone-estradiol on blood pressure and potassium balance in hypertensive postmenopausal women receiving hydrochlorothiazide. Menopause 2007;14:1–7
   PubMedGoogle Scholar
• Schürmann R, Blode H, Benda N, Cronin M, Küfner A. Effect of drospirenone on serum potassium and drospirenone pharmacokinetics in women with normal or impaired renal function. J Clin Pharmacol 2006;46:867–875
   PubMed Web of Science ®Google Scholar
• Svetkey LP. Management of prehypertension. Hypertension 2005;45:1056–1061
   PubMed Web of Science ®Google Scholar